Institutional investors hold a majority ownership of MYGN through the 143.55% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2014, these large investors purchased a net $3.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HSBC GLOBAL ASSET MANAGEMENT (DE... Bought 4.0 Thousand shares of Myriad Genetics Inc
NEW YORK LIFE INVESTMENT MANAGEM... Bought 621.00 shares of Myriad Genetics Inc
CAVANAL HILL INVESTMENT MANAGEME... Sold 637.00 shares of Myriad Genetics Inc